These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27226574)

  • 1. Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection.
    LoRicco JG; Xu CS; Neidleman J; Bergkvist M; Greene WC; Roan NR; Makhatadze GI
    J Biol Chem; 2016 Jul; 291(27):14045-14055. PubMed ID: 27226574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.
    Roan NR; Liu H; Usmani SM; Neidleman J; Müller JA; Avila-Herrera A; Gawanbacht A; Zirafi O; Chu S; Dong M; Kumar ST; Smith JF; Pollard KS; Fändrich M; Kirchhoff F; Münch J; Witkowska HE; Greene WC
    J Virol; 2014 Jul; 88(13):7221-34. PubMed ID: 24741080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
    Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
    J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
    Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
    Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
    Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S
    J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
    Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
    PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
    Elias AK; Scanlon D; Musgrave IF; Carver JA
    Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
    Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC
    J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
    Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PSB0739 inhibits formation of semen-derived amyloid fibril].
    Lan Y; Yang Z; Liu H; Cheng H; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1338-1343. PubMed ID: 30514682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.
    Roan NR; Müller JA; Liu H; Chu S; Arnold F; Stürzel CM; Walther P; Dong M; Witkowska HE; Kirchhoff F; Münch J; Greene WC
    Cell Host Microbe; 2011 Dec; 10(6):541-50. PubMed ID: 22177559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.
    Usmani SM; Zirafi O; Müller JA; Sandi-Monroy NL; Yadav JK; Meier C; Weil T; Roan NR; Greene WC; Walther P; Nilsson KP; Hammarström P; Wetzel R; Pilcher CD; Gagsteiger F; Fändrich M; Kirchhoff F; Münch J
    Nat Commun; 2014 Apr; 5():3508. PubMed ID: 24691351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.
    French KC; Roan NR; Makhatadze GI
    Biochemistry; 2014 May; 53(20):3267-77. PubMed ID: 24811874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.
    Castellano LM; Hammond RM; Holmes VM; Weissman D; Shorter J
    Biol Open; 2015 Aug; 4(9):1206-12. PubMed ID: 26319581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI).
    Elias AK; Wilson MR; Carver JA; Musgrave IF
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semen-derived amyloid fibrils drastically enhance HIV infection.
    Münch J; Rücker E; Ständker L; Adermann K; Goffinet C; Schindler M; Wildum S; Chinnadurai R; Rajan D; Specht A; Giménez-Gallego G; Sánchez PC; Fowler DM; Koulov A; Kelly JW; Mothes W; Grivel JC; Margolis L; Keppler OT; Forssmann WG; Kirchhoff F
    Cell; 2007 Dec; 131(6):1059-71. PubMed ID: 18083097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.
    Sheik DA; Dewhurst S; Yang J
    Acc Chem Res; 2017 Sep; 50(9):2159-2166. PubMed ID: 28809479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.
    Castellano LM; Bart SM; Holmes VM; Weissman D; Shorter J
    Chem Biol; 2015 Aug; 22(8):1074-86. PubMed ID: 26256479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
    Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
    J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection.
    Torres L; Ortiz T; Tang Q
    Viruses; 2015 Apr; 7(4):2057-73. PubMed ID: 25903833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.